Understanding Sedimentation Velocity Analytical Ultracentrifugation
Source: KBI Biopharma
A recent webinar discussed the use of sedimentation velocity analytical ultracentrifugation (SV-AUC) to characterize and quantify adeno-associated virus (AAV) species. It was followed by a Q&A with presenter N. Karl Maluf, Ph.D., Director of the Biophysical Characterization Core at KBI Biopharma.
Queries from the webinar audience concerned material preservation for further testing after SV-AUC; required particle concentrations; comparisons between SV-AUC and mass photometry analysis; limitations to the formula conditions in which samples are analyzed; and more.
access the Q&A!
Log In
Get unlimited access to:
Trend and Thought Leadership Articles
Case Studies & White Papers
Extensive Product Database
Members-Only Premium Content
Welcome Back! Please Log In to Continue.
X
Enter your credentials below to log in. Not yet a member of Bioprocess Online? Subscribe today.
Subscribe to Bioprocess Online
X
Subscribe to Bioprocess Online
KBI Biopharma
This website uses cookies to ensure you get the best experience on our website. Learn more